nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—CYP2C8—Simvastatin—atherosclerosis	0.228	0.338	CbGbCtD
Mometasone—CYP2C8—Lovastatin—atherosclerosis	0.223	0.331	CbGbCtD
Mometasone—CYP2C8—Pravastatin—atherosclerosis	0.223	0.331	CbGbCtD
Mometasone—Furunculosis—Niacin—atherosclerosis	0.00707	0.0252	CcSEcCtD
Mometasone—Trauma—Pravastatin—atherosclerosis	0.00622	0.0221	CcSEcCtD
Mometasone—Furuncle—Niacin—atherosclerosis	0.00613	0.0218	CcSEcCtD
Mometasone—Haemoptysis—Niacin—atherosclerosis	0.00406	0.0145	CcSEcCtD
Mometasone—Glaucoma—Niacin—atherosclerosis	0.00399	0.0142	CcSEcCtD
Mometasone—Endocrine disorder—Simvastatin—atherosclerosis	0.00395	0.0141	CcSEcCtD
Mometasone—Viral infection—Ezetimibe—atherosclerosis	0.0038	0.0135	CcSEcCtD
Mometasone—Tingling sensation—Niacin—atherosclerosis	0.00374	0.0133	CcSEcCtD
Mometasone—Cataract—Lovastatin—atherosclerosis	0.00368	0.0131	CcSEcCtD
Mometasone—Musculoskeletal pain—Lovastatin—atherosclerosis	0.00354	0.0126	CcSEcCtD
Mometasone—Cataract—Simvastatin—atherosclerosis	0.00344	0.0122	CcSEcCtD
Mometasone—Gastroenteritis—Rosuvastatin—atherosclerosis	0.00338	0.012	CcSEcCtD
Mometasone—Skin discolouration—Niacin—atherosclerosis	0.00333	0.0118	CcSEcCtD
Mometasone—Viral infection—Pravastatin—atherosclerosis	0.00328	0.0117	CcSEcCtD
Mometasone—Injury—Rosuvastatin—atherosclerosis	0.00326	0.0116	CcSEcCtD
Mometasone—Cataract—Pravastatin—atherosclerosis	0.00311	0.0111	CcSEcCtD
Mometasone—Musculoskeletal pain—Pravastatin—atherosclerosis	0.003	0.0107	CcSEcCtD
Mometasone—Dermatitis contact—Niacin—atherosclerosis	0.00297	0.0106	CcSEcCtD
Mometasone—Injury—Lovastatin—atherosclerosis	0.00277	0.00984	CcSEcCtD
Mometasone—Influenza—Rosuvastatin—atherosclerosis	0.00259	0.00922	CcSEcCtD
Mometasone—Bronchitis—Rosuvastatin—atherosclerosis	0.00249	0.00887	CcSEcCtD
Mometasone—Injury—Pravastatin—atherosclerosis	0.00234	0.00832	CcSEcCtD
Mometasone—Betamethasone—PLA2G1B—atherosclerosis	0.00225	0.376	CrCbGaD
Mometasone—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00225	0.00799	CcSEcCtD
Mometasone—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00223	0.00793	CcSEcCtD
Mometasone—Influenza—Lovastatin—atherosclerosis	0.0022	0.00781	CcSEcCtD
Mometasone—Sinusitis—Rosuvastatin—atherosclerosis	0.00217	0.00771	CcSEcCtD
Mometasone—Influenza—Ezetimibe—atherosclerosis	0.00215	0.00766	CcSEcCtD
Mometasone—Rhinitis—Rosuvastatin—atherosclerosis	0.00208	0.0074	CcSEcCtD
Mometasone—Pharyngitis—Rosuvastatin—atherosclerosis	0.00206	0.00732	CcSEcCtD
Mometasone—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.002	0.00712	CcSEcCtD
Mometasone—Bronchitis—Simvastatin—atherosclerosis	0.00198	0.00703	CcSEcCtD
Mometasone—Nasopharyngitis—Pravastatin—atherosclerosis	0.00192	0.00684	CcSEcCtD
Mometasone—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00191	0.00679	CcSEcCtD
Mometasone—Urinary tract infection—Lovastatin—atherosclerosis	0.0019	0.00677	CcSEcCtD
Mometasone—Influenza—Niacin—atherosclerosis	0.00189	0.00671	CcSEcCtD
Mometasone—Influenza—Pravastatin—atherosclerosis	0.00186	0.00661	CcSEcCtD
Mometasone—Sinusitis—Lovastatin—atherosclerosis	0.00184	0.00654	CcSEcCtD
Mometasone—Bronchitis—Niacin—atherosclerosis	0.00181	0.00645	CcSEcCtD
Mometasone—Sinusitis—Ezetimibe—atherosclerosis	0.0018	0.00641	CcSEcCtD
Mometasone—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00173	0.00614	CcSEcCtD
Mometasone—Sinusitis—Simvastatin—atherosclerosis	0.00172	0.00611	CcSEcCtD
Mometasone—Pharyngitis—Ezetimibe—atherosclerosis	0.00171	0.00609	CcSEcCtD
Mometasone—Angioedema—Rosuvastatin—atherosclerosis	0.00165	0.00587	CcSEcCtD
Mometasone—Urinary tract infection—Pravastatin—atherosclerosis	0.00161	0.00573	CcSEcCtD
Mometasone—Cough—Rosuvastatin—atherosclerosis	0.00158	0.00561	CcSEcCtD
Mometasone—Immune system disorder—Ezetimibe—atherosclerosis	0.00156	0.00554	CcSEcCtD
Mometasone—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00155	0.00553	CcSEcCtD
Mometasone—Sinusitis—Pravastatin—atherosclerosis	0.00155	0.00553	CcSEcCtD
Mometasone—Arthralgia—Rosuvastatin—atherosclerosis	0.00154	0.00547	CcSEcCtD
Mometasone—Myalgia—Rosuvastatin—atherosclerosis	0.00154	0.00547	CcSEcCtD
Mometasone—Rhinitis—Niacin—atherosclerosis	0.00151	0.00538	CcSEcCtD
Mometasone—Rhinitis—Pravastatin—atherosclerosis	0.00149	0.0053	CcSEcCtD
Mometasone—Back pain—Lovastatin—atherosclerosis	0.00148	0.00527	CcSEcCtD
Mometasone—Pharyngitis—Pravastatin—atherosclerosis	0.00148	0.00525	CcSEcCtD
Mometasone—Infection—Rosuvastatin—atherosclerosis	0.00146	0.00521	CcSEcCtD
Mometasone—Back pain—Ezetimibe—atherosclerosis	0.00145	0.00517	CcSEcCtD
Mometasone—Angioedema—Lovastatin—atherosclerosis	0.0014	0.00497	CcSEcCtD
Mometasone—Angioedema—Ezetimibe—atherosclerosis	0.00137	0.00488	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00134	0.00478	CcSEcCtD
Mometasone—Paraesthesia—Rosuvastatin—atherosclerosis	0.00132	0.00471	CcSEcCtD
Mometasone—Cough—Ezetimibe—atherosclerosis	0.00131	0.00466	CcSEcCtD
Mometasone—Angioedema—Simvastatin—atherosclerosis	0.00131	0.00465	CcSEcCtD
Mometasone—Dexamethasone—PLA2G1B—atherosclerosis	0.00131	0.219	CrCbGaD
Mometasone—Myalgia—Lovastatin—atherosclerosis	0.0013	0.00463	CcSEcCtD
Mometasone—Arthralgia—Lovastatin—atherosclerosis	0.0013	0.00463	CcSEcCtD
Mometasone—Chest pain—Lovastatin—atherosclerosis	0.0013	0.00463	CcSEcCtD
Mometasone—Dyspepsia—Rosuvastatin—atherosclerosis	0.0013	0.00462	CcSEcCtD
Mometasone—Arthralgia—Ezetimibe—atherosclerosis	0.00128	0.00455	CcSEcCtD
Mometasone—Chest pain—Ezetimibe—atherosclerosis	0.00128	0.00455	CcSEcCtD
Mometasone—Myalgia—Ezetimibe—atherosclerosis	0.00128	0.00455	CcSEcCtD
Mometasone—Dry mouth—Lovastatin—atherosclerosis	0.00127	0.00453	CcSEcCtD
Mometasone—Pain—Rosuvastatin—atherosclerosis	0.00126	0.00448	CcSEcCtD
Mometasone—Dry mouth—Ezetimibe—atherosclerosis	0.00125	0.00445	CcSEcCtD
Mometasone—Anaphylactic shock—Lovastatin—atherosclerosis	0.00125	0.00444	CcSEcCtD
Mometasone—Infection—Lovastatin—atherosclerosis	0.00124	0.00441	CcSEcCtD
Mometasone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00123	0.00436	CcSEcCtD
Mometasone—Chest pain—Simvastatin—atherosclerosis	0.00122	0.00434	CcSEcCtD
Mometasone—Myalgia—Simvastatin—atherosclerosis	0.00122	0.00434	CcSEcCtD
Mometasone—Arthralgia—Simvastatin—atherosclerosis	0.00122	0.00434	CcSEcCtD
Mometasone—Infection—Ezetimibe—atherosclerosis	0.00122	0.00433	CcSEcCtD
Mometasone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00121	0.00429	CcSEcCtD
Mometasone—Angioedema—Niacin—atherosclerosis	0.0012	0.00427	CcSEcCtD
Mometasone—Anorexia—Lovastatin—atherosclerosis	0.00119	0.00424	CcSEcCtD
Mometasone—Angioedema—Pravastatin—atherosclerosis	0.00118	0.00421	CcSEcCtD
Mometasone—Anaphylactic shock—Simvastatin—atherosclerosis	0.00117	0.00416	CcSEcCtD
Mometasone—Abdominal pain—Rosuvastatin—atherosclerosis	0.00117	0.00414	CcSEcCtD
Mometasone—Infection—Simvastatin—atherosclerosis	0.00116	0.00413	CcSEcCtD
Mometasone—Cough—Niacin—atherosclerosis	0.00115	0.00408	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—atherosclerosis	0.00115	0.03	CbGpPWpGaD
Mometasone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00114	0.00405	CcSEcCtD
Mometasone—Cough—Pravastatin—atherosclerosis	0.00113	0.00402	CcSEcCtD
Mometasone—Paraesthesia—Lovastatin—atherosclerosis	0.00112	0.00399	CcSEcCtD
Mometasone—Arthralgia—Niacin—atherosclerosis	0.00112	0.00398	CcSEcCtD
Mometasone—Myalgia—Niacin—atherosclerosis	0.00112	0.00398	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00112	0.00397	CcSEcCtD
Mometasone—Anorexia—Simvastatin—atherosclerosis	0.00111	0.00396	CcSEcCtD
Mometasone—Dyspnoea—Lovastatin—atherosclerosis	0.00111	0.00396	CcSEcCtD
Mometasone—Arthralgia—Pravastatin—atherosclerosis	0.0011	0.00392	CcSEcCtD
Mometasone—Myalgia—Pravastatin—atherosclerosis	0.0011	0.00392	CcSEcCtD
Mometasone—Chest pain—Pravastatin—atherosclerosis	0.0011	0.00392	CcSEcCtD
Mometasone—Paraesthesia—Ezetimibe—atherosclerosis	0.0011	0.00391	CcSEcCtD
Mometasone—Dyspepsia—Lovastatin—atherosclerosis	0.0011	0.00391	CcSEcCtD
Mometasone—Dry mouth—Niacin—atherosclerosis	0.00109	0.00389	CcSEcCtD
Mometasone—Dyspnoea—Ezetimibe—atherosclerosis	0.00109	0.00389	CcSEcCtD
Mometasone—Decreased appetite—Lovastatin—atherosclerosis	0.00109	0.00386	CcSEcCtD
Mometasone—Dyspepsia—Ezetimibe—atherosclerosis	0.00108	0.00384	CcSEcCtD
Mometasone—Fatigue—Lovastatin—atherosclerosis	0.00108	0.00383	CcSEcCtD
Mometasone—Anaphylactic shock—Niacin—atherosclerosis	0.00107	0.00382	CcSEcCtD
Mometasone—Pain—Lovastatin—atherosclerosis	0.00107	0.0038	CcSEcCtD
Mometasone—Decreased appetite—Ezetimibe—atherosclerosis	0.00107	0.00379	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00106	0.00379	CcSEcCtD
Mometasone—Asthenia—Rosuvastatin—atherosclerosis	0.00106	0.00376	CcSEcCtD
Mometasone—Anaphylactic shock—Pravastatin—atherosclerosis	0.00106	0.00376	CcSEcCtD
Mometasone—Fatigue—Ezetimibe—atherosclerosis	0.00106	0.00376	CcSEcCtD
Mometasone—Infection—Pravastatin—atherosclerosis	0.00105	0.00373	CcSEcCtD
Mometasone—Paraesthesia—Simvastatin—atherosclerosis	0.00105	0.00373	CcSEcCtD
Mometasone—Pain—Ezetimibe—atherosclerosis	0.00105	0.00373	CcSEcCtD
Mometasone—Pruritus—Rosuvastatin—atherosclerosis	0.00104	0.00371	CcSEcCtD
Mometasone—Dyspnoea—Simvastatin—atherosclerosis	0.00104	0.00371	CcSEcCtD
Mometasone—Dyspepsia—Simvastatin—atherosclerosis	0.00103	0.00366	CcSEcCtD
Mometasone—Anorexia—Niacin—atherosclerosis	0.00102	0.00364	CcSEcCtD
Mometasone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00102	0.00363	CcSEcCtD
Mometasone—Decreased appetite—Simvastatin—atherosclerosis	0.00102	0.00361	CcSEcCtD
Mometasone—Diarrhoea—Rosuvastatin—atherosclerosis	0.00101	0.00359	CcSEcCtD
Mometasone—Fatigue—Simvastatin—atherosclerosis	0.00101	0.00358	CcSEcCtD
Mometasone—Anorexia—Pravastatin—atherosclerosis	0.00101	0.00358	CcSEcCtD
Mometasone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.001	0.00356	CcSEcCtD
Mometasone—Pain—Simvastatin—atherosclerosis	0.000999	0.00355	CcSEcCtD
Mometasone—Abdominal pain—Lovastatin—atherosclerosis	0.000987	0.00351	CcSEcCtD
Mometasone—Body temperature increased—Lovastatin—atherosclerosis	0.000987	0.00351	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000977	0.00348	CcSEcCtD
Mometasone—Body temperature increased—Ezetimibe—atherosclerosis	0.000969	0.00345	CcSEcCtD
Mometasone—Abdominal pain—Ezetimibe—atherosclerosis	0.000969	0.00345	CcSEcCtD
Mometasone—Paraesthesia—Niacin—atherosclerosis	0.000963	0.00343	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000962	0.00342	CcSEcCtD
Mometasone—Dyspnoea—Niacin—atherosclerosis	0.000956	0.0034	CcSEcCtD
Mometasone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000955	0.0034	CcSEcCtD
Mometasone—Paraesthesia—Pravastatin—atherosclerosis	0.000949	0.00337	CcSEcCtD
Mometasone—Dyspepsia—Niacin—atherosclerosis	0.000944	0.00336	CcSEcCtD
Mometasone—Dyspnoea—Pravastatin—atherosclerosis	0.000942	0.00335	CcSEcCtD
Mometasone—CYP2C8—Arachidonic acid metabolism—LTA4H—atherosclerosis	0.000935	0.0245	CbGpPWpGaD
Mometasone—Decreased appetite—Niacin—atherosclerosis	0.000933	0.00332	CcSEcCtD
Mometasone—Dyspepsia—Pravastatin—atherosclerosis	0.00093	0.00331	CcSEcCtD
Mometasone—Rash—Rosuvastatin—atherosclerosis	0.000929	0.00331	CcSEcCtD
Mometasone—Dermatitis—Rosuvastatin—atherosclerosis	0.000929	0.0033	CcSEcCtD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—atherosclerosis	0.000924	0.0242	CbGpPWpGaD
Mometasone—Body temperature increased—Simvastatin—atherosclerosis	0.000924	0.00329	CcSEcCtD
Mometasone—Abdominal pain—Simvastatin—atherosclerosis	0.000924	0.00329	CcSEcCtD
Mometasone—Headache—Rosuvastatin—atherosclerosis	0.000923	0.00328	CcSEcCtD
Mometasone—Decreased appetite—Pravastatin—atherosclerosis	0.000918	0.00327	CcSEcCtD
Mometasone—Pain—Niacin—atherosclerosis	0.000917	0.00326	CcSEcCtD
Mometasone—Fatigue—Pravastatin—atherosclerosis	0.000911	0.00324	CcSEcCtD
Mometasone—Pain—Pravastatin—atherosclerosis	0.000903	0.00321	CcSEcCtD
Mometasone—Asthenia—Lovastatin—atherosclerosis	0.000896	0.00319	CcSEcCtD
Mometasone—Pruritus—Lovastatin—atherosclerosis	0.000884	0.00314	CcSEcCtD
Mometasone—Asthenia—Ezetimibe—atherosclerosis	0.000879	0.00313	CcSEcCtD
Mometasone—Gastrointestinal pain—Niacin—atherosclerosis	0.000877	0.00312	CcSEcCtD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—atherosclerosis	0.000876	0.0229	CbGpPWpGaD
Mometasone—Nausea—Rosuvastatin—atherosclerosis	0.000876	0.00311	CcSEcCtD
Mometasone—Pruritus—Ezetimibe—atherosclerosis	0.000867	0.00308	CcSEcCtD
Mometasone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000864	0.00307	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—FABP4—atherosclerosis	0.000861	0.0225	CbGpPWpGaD
Mometasone—Diarrhoea—Lovastatin—atherosclerosis	0.000855	0.00304	CcSEcCtD
Mometasone—Abdominal pain—Niacin—atherosclerosis	0.000848	0.00302	CcSEcCtD
Mometasone—Body temperature increased—Niacin—atherosclerosis	0.000848	0.00302	CcSEcCtD
Mometasone—Asthenia—Simvastatin—atherosclerosis	0.000838	0.00298	CcSEcCtD
Mometasone—Diarrhoea—Ezetimibe—atherosclerosis	0.000838	0.00298	CcSEcCtD
Mometasone—Abdominal pain—Pravastatin—atherosclerosis	0.000835	0.00297	CcSEcCtD
Mometasone—Body temperature increased—Pravastatin—atherosclerosis	0.000835	0.00297	CcSEcCtD
Mometasone—Pruritus—Simvastatin—atherosclerosis	0.000827	0.00294	CcSEcCtD
Mometasone—Diarrhoea—Simvastatin—atherosclerosis	0.000799	0.00284	CcSEcCtD
Mometasone—Vomiting—Lovastatin—atherosclerosis	0.000794	0.00283	CcSEcCtD
Mometasone—Rash—Lovastatin—atherosclerosis	0.000788	0.0028	CcSEcCtD
Mometasone—Dermatitis—Lovastatin—atherosclerosis	0.000787	0.0028	CcSEcCtD
Mometasone—Headache—Lovastatin—atherosclerosis	0.000783	0.00278	CcSEcCtD
Mometasone—Vomiting—Ezetimibe—atherosclerosis	0.000779	0.00277	CcSEcCtD
Mometasone—Rash—Ezetimibe—atherosclerosis	0.000773	0.00275	CcSEcCtD
Mometasone—Dermatitis—Ezetimibe—atherosclerosis	0.000772	0.00275	CcSEcCtD
Mometasone—Asthenia—Niacin—atherosclerosis	0.00077	0.00274	CcSEcCtD
Mometasone—Headache—Ezetimibe—atherosclerosis	0.000768	0.00273	CcSEcCtD
Mometasone—Pruritus—Niacin—atherosclerosis	0.000759	0.0027	CcSEcCtD
Mometasone—Asthenia—Pravastatin—atherosclerosis	0.000758	0.0027	CcSEcCtD
Mometasone—Pruritus—Pravastatin—atherosclerosis	0.000747	0.00266	CcSEcCtD
Mometasone—Vomiting—Simvastatin—atherosclerosis	0.000743	0.00264	CcSEcCtD
Mometasone—Nausea—Lovastatin—atherosclerosis	0.000742	0.00264	CcSEcCtD
Mometasone—Fluoxymesterone—ESR1—atherosclerosis	0.00074	0.124	CrCbGaD
Mometasone—Rash—Simvastatin—atherosclerosis	0.000737	0.00262	CcSEcCtD
Mometasone—Dermatitis—Simvastatin—atherosclerosis	0.000736	0.00262	CcSEcCtD
Mometasone—Diarrhoea—Niacin—atherosclerosis	0.000734	0.00261	CcSEcCtD
Mometasone—Headache—Simvastatin—atherosclerosis	0.000732	0.0026	CcSEcCtD
Mometasone—Nausea—Ezetimibe—atherosclerosis	0.000728	0.00259	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptors—ESR2—atherosclerosis	0.000724	0.0189	CbGpPWpGaD
Mometasone—Diarrhoea—Pravastatin—atherosclerosis	0.000723	0.00257	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—atherosclerosis	0.000712	0.0186	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—RETN—atherosclerosis	0.000706	0.0185	CbGpPWpGaD
Mometasone—Nausea—Simvastatin—atherosclerosis	0.000694	0.00247	CcSEcCtD
Mometasone—Vomiting—Niacin—atherosclerosis	0.000682	0.00243	CcSEcCtD
Mometasone—Rash—Niacin—atherosclerosis	0.000676	0.00241	CcSEcCtD
Mometasone—Dermatitis—Niacin—atherosclerosis	0.000676	0.0024	CcSEcCtD
Mometasone—NR3C1—Circadian Clock—NAMPT—atherosclerosis	0.000673	0.0176	CbGpPWpGaD
Mometasone—Headache—Niacin—atherosclerosis	0.000672	0.00239	CcSEcCtD
Mometasone—Vomiting—Pravastatin—atherosclerosis	0.000672	0.00239	CcSEcCtD
Mometasone—Rash—Pravastatin—atherosclerosis	0.000666	0.00237	CcSEcCtD
Mometasone—Dermatitis—Pravastatin—atherosclerosis	0.000665	0.00237	CcSEcCtD
Mometasone—Headache—Pravastatin—atherosclerosis	0.000662	0.00235	CcSEcCtD
Mometasone—NR3C1—Circadian Clock—F7—atherosclerosis	0.000638	0.0167	CbGpPWpGaD
Mometasone—Nausea—Niacin—atherosclerosis	0.000637	0.00227	CcSEcCtD
Mometasone—Nausea—Pravastatin—atherosclerosis	0.000627	0.00223	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—atherosclerosis	0.00062	0.0162	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—ALOX15—atherosclerosis	0.000587	0.0154	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—ALOX5AP—atherosclerosis	0.000587	0.0154	CbGpPWpGaD
Mometasone—Dexamethasone—NOS2—atherosclerosis	0.000584	0.0978	CrCbGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000579	0.0152	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.000572	0.015	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000572	0.015	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—SELE—atherosclerosis	0.000545	0.0143	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000535	0.014	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000528	0.0138	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—ALOX5—atherosclerosis	0.000499	0.0131	CbGpPWpGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atherosclerosis	0.000495	0.013	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—PPARA—atherosclerosis	0.000485	0.0127	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00047	0.0123	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.000447	0.0117	CbGpPWpGaD
Mometasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.000439	0.0115	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.000439	0.0115	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000434	0.0114	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.000416	0.0109	CbGpPWpGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.000409	0.0107	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000404	0.0106	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.0004	0.0105	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—AHR—atherosclerosis	0.000387	0.0101	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.000386	0.0101	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.000383	0.01	CbGpPWpGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.000369	0.00964	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.00036	0.00943	CbGpPWpGaD
Mometasone—Triamcinolone—PTGS2—atherosclerosis	0.000352	0.0589	CrCbGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000349	0.00914	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.000347	0.00908	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.000347	0.00907	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.000344	0.00899	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.000343	0.00897	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.000338	0.00885	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.000329	0.00862	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.00032	0.00838	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.000316	0.00828	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.000305	0.00798	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.000291	0.00763	CbGpPWpGaD
Mometasone—Betamethasone—PTGS2—atherosclerosis	0.000288	0.0483	CrCbGaD
Mometasone—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.000288	0.00753	CbGpPWpGaD
Mometasone—Prednisone—ALB—atherosclerosis	0.000284	0.0476	CrCbGaD
Mometasone—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.000277	0.00724	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.000269	0.00705	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.000268	0.00702	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.000266	0.00695	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—GPX1—atherosclerosis	0.000265	0.00693	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.000257	0.00672	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP7A1—atherosclerosis	0.000249	0.00653	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000246	0.00644	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.00024	0.00627	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.000237	0.0062	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.000234	0.00612	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.000233	0.00611	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP27A1—atherosclerosis	0.000231	0.00603	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.00023	0.00602	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000227	0.00595	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.000206	0.00539	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—LPL—atherosclerosis	0.000205	0.00537	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000202	0.00527	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000197	0.00515	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000187	0.0049	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.000181	0.00474	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000181	0.00472	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000178	0.00465	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—AGT—atherosclerosis	0.000175	0.00459	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000172	0.0045	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.00017	0.00444	CbGpPWpGaD
Mometasone—Dexamethasone—PTGS2—atherosclerosis	0.000168	0.0281	CrCbGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000165	0.00432	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000164	0.00429	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.000156	0.00408	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000154	0.00403	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.00015	0.00392	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000148	0.00387	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—INS—atherosclerosis	0.000147	0.00384	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000145	0.0038	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000143	0.00374	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.000142	0.00372	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000141	0.00368	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.00014	0.00366	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.000135	0.00353	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000134	0.0035	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000134	0.0035	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.000127	0.00332	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000106	0.00276	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000105	0.00275	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000104	0.00273	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTM1—atherosclerosis	0.000103	0.00269	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTM1—atherosclerosis	0.000102	0.00266	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	9.93e-05	0.0026	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	9.93e-05	0.0026	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	9.88e-05	0.00259	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	9.87e-05	0.00258	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	9.75e-05	0.00255	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	9.58e-05	0.00251	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	9.47e-05	0.00248	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	9.28e-05	0.00243	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—STAT3—atherosclerosis	9.19e-05	0.0024	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	8.85e-05	0.00232	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	8.83e-05	0.00231	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	8.64e-05	0.00226	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	8.56e-05	0.00224	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TGFB1—atherosclerosis	8.52e-05	0.00223	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	8.39e-05	0.0022	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	8.39e-05	0.0022	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	8.39e-05	0.0022	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	8.39e-05	0.0022	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	8.29e-05	0.00217	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	8.02e-05	0.0021	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	8.01e-05	0.00209	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TNF—atherosclerosis	7.95e-05	0.00208	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	7.68e-05	0.00201	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	7.39e-05	0.00193	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LDLRAP1—atherosclerosis	7.3e-05	0.00191	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	7.14e-05	0.00187	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	6.87e-05	0.0018	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PLTP—atherosclerosis	6.86e-05	0.0018	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	6.61e-05	0.00173	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—atherosclerosis	6.42e-05	0.00168	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	6.36e-05	0.00166	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	6.32e-05	0.00165	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	6.28e-05	0.00164	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	6.14e-05	0.00161	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	5.99e-05	0.00157	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LTA4H—atherosclerosis	5.95e-05	0.00156	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCG8—atherosclerosis	5.95e-05	0.00156	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.88e-05	0.00154	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HSPA1B—atherosclerosis	5.64e-05	0.00147	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.55e-05	0.00145	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	5.55e-05	0.00145	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	5.47e-05	0.00143	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PARP1—atherosclerosis	5.02e-05	0.00131	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.95e-05	0.00129	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	4.93e-05	0.00129	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ESR2—atherosclerosis	4.76e-05	0.00124	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCG1—atherosclerosis	4.7e-05	0.00123	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LCAT—atherosclerosis	4.42e-05	0.00116	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—FABP4—atherosclerosis	4.42e-05	0.00116	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOA4—atherosclerosis	4.34e-05	0.00114	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP7A1—atherosclerosis	4.27e-05	0.00112	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.06e-05	0.00106	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP27A1—atherosclerosis	3.94e-05	0.00103	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.88e-05	0.00102	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SIRT1—atherosclerosis	3.83e-05	0.001	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.79e-05	0.000991	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOA2—atherosclerosis	3.74e-05	0.000978	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	3.74e-05	0.000978	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALOX15—atherosclerosis	3.74e-05	0.000978	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	3.74e-05	0.000978	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCG5—atherosclerosis	3.69e-05	0.000966	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.69e-05	0.000965	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LPA—atherosclerosis	3.57e-05	0.000933	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—BGN—atherosclerosis	3.45e-05	0.000904	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.43e-05	0.000897	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOA5—atherosclerosis	3.42e-05	0.000894	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.32e-05	0.000869	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	3.29e-05	0.000861	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.25e-05	0.000851	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.22e-05	0.000843	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.22e-05	0.000842	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPARA—atherosclerosis	3.18e-05	0.000833	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALOX5—atherosclerosis	3.18e-05	0.000832	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.94e-05	0.000768	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ESR1—atherosclerosis	2.88e-05	0.000755	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NAMPT—atherosclerosis	2.85e-05	0.000746	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.83e-05	0.000741	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LIPC—atherosclerosis	2.83e-05	0.000741	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOC3—atherosclerosis	2.82e-05	0.000737	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LDLR—atherosclerosis	2.8e-05	0.000732	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CETP—atherosclerosis	2.73e-05	0.000715	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPARG—atherosclerosis	2.63e-05	0.000689	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SCARB1—atherosclerosis	2.62e-05	0.000685	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.55e-05	0.000667	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HMGCR—atherosclerosis	2.47e-05	0.000647	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SERPINE1—atherosclerosis	2.37e-05	0.00062	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.23e-05	0.000583	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCA1—atherosclerosis	2.2e-05	0.000576	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.89e-05	0.000495	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOB—atherosclerosis	1.81e-05	0.000474	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTM1—atherosclerosis	1.76e-05	0.000461	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LPL—atherosclerosis	1.73e-05	0.000452	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GPX1—atherosclerosis	1.69e-05	0.000441	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CD36—atherosclerosis	1.64e-05	0.00043	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTHFR—atherosclerosis	1.56e-05	0.000407	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MAPK3—atherosclerosis	1.54e-05	0.000404	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARA—atherosclerosis	1.53e-05	0.0004	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AGT—atherosclerosis	1.48e-05	0.000387	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOE—atherosclerosis	1.45e-05	0.000379	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CAV1—atherosclerosis	1.44e-05	0.000376	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOA1—atherosclerosis	1.43e-05	0.000375	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CG—atherosclerosis	1.31e-05	0.000342	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARG—atherosclerosis	1.26e-05	0.00033	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—INS—atherosclerosis	1.24e-05	0.000324	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALB—atherosclerosis	1.13e-05	0.000297	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NOS3—atherosclerosis	1.09e-05	0.000284	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AKT1—atherosclerosis	1.04e-05	0.000272	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGS2—atherosclerosis	9.93e-06	0.00026	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKT1—atherosclerosis	4.99e-06	0.000131	CbGpPWpGaD
